We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
126
Texas Instruments
TXN
$255B
$18.5M 0.25%
241,116
– –
HCA icon
127
HCA Healthcare
HCA
$84.8B
$17.5M 0.24%
200,908
+111,908
+126% +$9.47M
AFL icon
128
Aflac
AFL
$63.9B
$17.5M 0.24%
450,100
+14,300
+3% +$537K
AXS icon
129
AXIS Capital
AXS
$8.59B
$16.5M 0.22%
255,000
+30,000
+13% +$1.96M
STE icon
130
Steris
STE
$20.9B
$16.3M 0.22%
+200,000
New +$15.2M
ANSS
131
DELISTED
Ansys
ANSS
$16.2M 0.22%
+133,400
New +$15.7M
RLI icon
132
RLI Corp
RLI
$5.68B
$16.2M 0.22%
591,800
+88,200
+18% +$2.48M
SCHW
133
Charles Schwab
SCHW
$177B
$15.6M 0.21%
362,872
– –
LH icon
134
Labcorp
LH
$24.3B
$15.3M 0.21%
115,855
-89,009
-43% -$10.9M
OMCL icon
135
Omnicell
OMCL
$1.86B
$14.5M 0.2%
+336,519
New +$14M
AVGO icon
136
Broadcom
AVGO
$1.82T
$14.2M 0.19%
609,190
+249,320
+69% +$5.78M
HRTG icon
137
Heritage Insurance Holdings
HRTG
$842M
$13.1M 0.18%
1,008,000
+8,000
+0.8% +$100K
ICUI icon
138
ICU Medical
ICUI
$3.93B
$12.3M 0.16%
+71,026
New +$11.4M
BKNG icon
139
Booking.com
BKNG
$138B
$11.4M 0.15%
152,225
+33,975
+29% +$2.49M
TD icon
140
Toronto Dominion Bank
TD
$198B
$10.6M 0.14%
181,441
-11,007
-6% -$531K
INGN icon
141
Inogen
INGN
$167M
$10.2M 0.14%
106,474
-31,558
-23% -$2.7M
RL icon
142
Ralph Lauren
RL
$22.2B
$10.1M 0.14%
137,229
– –
PAYC icon
143
Paycom
PAYC
$6.78B
$10.1M 0.14%
147,910
+5,250
+4% +$338K
FRC
144
DELISTED
First Republic Bank
FRC
$10.1M 0.14%
100,718
-4,343
-4% -$410K
WCN
145
Waste Connections
WCN
$42.8B
$9.97M 0.13%
154,769
-247,086
-61% -$15.4M
CNC icon
146
Centene
CNC
$31.3B
$9.78M 0.13%
245,082
+111,082
+83% +$4.19M
BRO icon
147
Brown & Brown
BRO
$22.9B
$9.73M 0.13%
451,900
+14,400
+3% +$309K
UBS icon
148
UBS Group
UBS
$170B
$9.61M 0.13%
564,769
+255,769
+83% +$4.16M
PNC icon
149
PNC Financial Services
PNC
$100B
$9.24M 0.12%
74,000
– –
ACM icon
150
Aecom
ACM
$9.07B
$9.14M 0.12%
282,766
-306,897
-52% -$10.2M
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.